| |
 |
Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors)
|
| |
|
pp.531-531 (1) Author: Vita M. Golubovskaya |
| |
|
|
| |
|
A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo
|
| |
|
pp.532-545 (14) Authors: Vita M. Golubovskaya, Nadia L. Palma, Min Zheng, Baotran Ho, Andrew Magis, David Ostrov, William G. Cance |
| |
|
|
| |
|
Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities
|
| |
|
pp.546-554 (9) Authors: Vita M. Golubovskaya, Baotran Ho, Min Zheng, Andrew Magis, David Ostrov, William G. Cance |
| |
|
|
| |
|
Upregulation of Focal Adhesion Kinase by 14-3-3 via NFκB Activation in Hepatocellular Carcinoma
|
| |
|
pp.555-562 (8) Authors: Bor-Sheng Ko, Yee-Jee Jan, Tzu-Ching Chang, Shu-Man Liang, Shyh-Chang Chen, Tzu-An Liu, Yao-Ming Wu, John Wang, Jun-Yang Liou |
| |
|
|
| |
|
Cell Survival Signaling in Neuroblastoma
|
| |
|
pp.563-575 (13) Authors: Michael L. Megison, Lauren A. Gillory, Elizabeth A. Beierle |
| |
|
|
| |
|
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
|
| |
|
pp.576-580 (5) Author: Vita M. Golubovskaya |
| |
|
|
| |
|
The Role of Focal Adhesion Kinase in Lung Cancer
|
| |
|
pp.581-583 (3) Author: Grace K. Dy |
| |
|
|
| |
|
FAK and HAS Inhibition Synergistically Decrease Colon Cancer Cell Viability and Affect Expression of Critical Genes
|
| |
|
pp.584-594 (11) Authors: Melissa Heffler, Vita M. Golubovskaya, Jeffrey Conroy, Song Liu, Dan Wang, William G. Cance, Kelli B. Dunn |
| |
|
|
| |
|
Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
|
| |
|
pp.595-602 (8) Authors: Deniz A. Ucar, Andrew T. Magis, Di-Hua He, Nicholas J. Lawrence, Said M. Sebti, Elena Kurenova, Maria Zajac-Kaye, Jianliang Zhang, Steven N. Hochwald |
| |
|
|
| |
|
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
|
| |
|
pp.603-631 (29) Authors: Karina Petit, Jean-Francois Biard |
| |
|
|
| |
|
Synthesis and Anticancer Properties of a Novel Bis-intercalator
|
| |
|
pp.632-638 (7) Authors: Wei Shen, Huimin Deng, Zhiqiang Gao |
| |
|
|
| |
|
Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins
|
| |
|
pp.639-646 (8) Authors: Galina V. Golovina, Georgy N. Rychkov, Valentina A. Ol’shevskaya, Andrei V. Zaitsev, Valery N. Kalinin, Vladimir A. Kuzmin, Alexander A. Shtil |
| |
|
|
| |
|
SJSZ Glycoprotein (38 kDa) Inhibits Cell Cycle and Oxidative Stress in N-Methyl-N`- nitro-N-nitrosoguanidine-induced ICR Mice
|
| |
|
pp.647-653 (7) Authors: Jin Lee, Kye-Taek Lim |
| |
|
|
| |
|
Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
|
| |
|
pp.654-662 (9) Authors: Giorgio Brandi, Alessandra Fraternale, Simone Lucarini, Mirko Paiardini, Mauro De Santi, Barbara Cervasi, Maria F. Paoletti, Luca Galluzzi, Andrea Duranti, Mauro Magnani |
| |
|
|
| |
|
Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF
|
| |
|
pp.663-671 (9) Authors: Qun Xie, Nanhong Tang, Rong Wan, Yuanlin Qi, Xu Lin, Jianyin Lin |
| |
|
|
